Skip to content

Effect of Ashvinimudra yogasana with bilva patra Kadha sitz bath Sweda in piles

An open randomized controlled clinical study to evaluate efficacy of Ashwini Mudra along with Bilva patra kati avgah sweda in the management of Gudarsh wsr to grade 1 and 2 haemorrhoids - Nill

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079202
Enrollment
60
Registered
2025-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

DR RAJASHREE KOLARKAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group: 20 to 50 years, Gender-Both, male and female. Patients diagnosed with Grade 1 & 2 Haemorrhoids who are not receiving any other treatment

Exclusion criteria

Exclusion criteria: Patients with Grade 3 and Grade 4 Haemorrhoids Malignant conditions Ca Rectum and accelerated hypertensive, patient with systemic diseases like HIV, VDRL, CKD etc. Patient with known complications of Haemorrhoids like Thrombosed, Strangulated Piles, Severe Anaemia etc. Post Haemorrhoidectomy patients, Fissure, Fistula complex cases Pregnant woman

Design outcomes

Primary

MeasureTime frame
1.To evaluate the therapeutic efficacy of Ashwini mudra along with Bilva Patra kati Avgah sweda in the management of symptomssuch as Bleeding per rectum, Size of pedicle, Colour of pedicles, Constipation and Pain.Timepoint: 015th DAY30th DAY45TH DAY60TH DAY75TH DAY90TH DAY

Secondary

MeasureTime frame
3. To establish Ashwini Mudra as an alternative regime for the management of first- and second-degree hemorrhoids and also for prevention from other ano rectal problems.Timepoint: THREE MONTHS

Countries

India

Contacts

Public ContactDwivedi Amarprakash

KG MITTAL AYURVED COLLEGE MUMBAI

rajashreekolarkar32@gmail.com9820064750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026